Sí
Quiénes somos
Niraparib and Panitumumab in Patients With Advanced or Metastatic Colorectal Cancer
A Study of Gene Edited Autologous Neoantigen Targeted TCR T Cells With or Without Anti-PD-1 in Patients With Solid Tumors
Investigation of a Therapeutic Vaccine (ACIT-1) in Cancer
Local Immunomodulation After Radiofrequency of Unresectable Colorectal Liver Metastases
Study of Lenvatinib (MK-7902/E7080) in Combination With Pembrolizumab (MK-3475) Versus Standard of Care in Participants With Metastatic Colorectal Cancer (MK-7902-017/E7080-G000-325/LEAP-017)
A Study of ABBV-927 and ABBV-181, an Immunotherapy, in Participants With Advanced Solid Tumors
Personalized Immunotherapy in Adults With Advanced Cancers Immunotherapy in Adults With Advanced Cancers
Adoptive Cell Therapy Across Cancer Diagnoses
Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
Regorafenib and Pembrolizumab in Treating Participants With Advanced or Metastatic Colorectal Cancer
